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Role of Smad4 on TGF-–induced extracellular matrix stimu- kidney diseases, including diabetic nephropathy [1–3].
lation in mesangial cells. TGF- induces renal fibrosis by stimulating the produc-
Background. The best characterized signaling pathway em-
tion of extracellular matrix (ECM), including type I, III,ployed by transforming growth factor- (TGF-) is the Smad
and IV collagen, fibronectin (FN), laminin, proteoglycanspathway; however, its role in matrix production in mesangial
cells is unclear. We focused on Smad4, as Smad4 is essential [4], and inhibiting the activity of enzymes that degrade
for the activation of Smad-dependent target genes. matrix proteins via plasminogen activator inhibitor-1Methods. To investigate the function of Smad4 in extracellu-
(PAI-1) [5]. Although the role of TGF- in progressivelar matrix (ECM) production, we generated several stably
transfected mesangial cell lines (MMC) that have a deletion fibrosis is accepted, the signaling pathway by which TGF-
in the linker region (Smad4M4: 275-322) or have a deletion stimulates matrix accumulation in kidney cells is not clear.
in MH1 of Smad4 (Smad4N4: 1-136). The ECM genes, 1 TGF- exerts its diverse effects by binding to twotype I collagen (COL1A1), plasminogen activator inhibitor-1
types of receptors with serine/threonine kinase activity.(PAI-1) and fibronectin (FN) were assessed in wild-type mesan-
gial cells and stably transfected Smad4-DN cell lines in the The ligand first binds to the type II receptor, which conse-
absence and presence of TGF-. quently activates the type I receptor by direct phosphory-
Results. As compared to wild-type MMC that had a 10.8-
lation. The activated type I receptor then phosphorylatesfold stimulation of TGF-–induced p3TP-Lux activity, MMC
receptor-regulated Smads (R-Smads), such as Smad2stably transfected with Smad4M4 and Smad4N4 had only a
2.0-fold and 1.3-fold stimulation, respectively, indicating that and Smad3. After R-Smads are phosphorylated by a type
they had dominant-negative effects on TGF- signaling. Basal I receptor, they form heteromers with Smad4, commonand TGF-–induced COL1A1 expression in Smad4 dominant-
pathway Smad (Co-Smad), and then translocate into thenegative cells were dramatically reduced to very low levels.
The early (2 hours) TGF-–induced PAI-1 mRNA expression nucleus where the complex activates transcription of spe-
was inhibited; however, the sustained (24 to 48 hours) TGF- cific genes [6–8]. TGF-–targeted genes are induced ei-
–induced expression was not affected in Smad4 dominant-
ther by direct binding of Smad complexes to the pro-negative cells. For FN, TGF-–induced expression was main-
moter, or by association of Smad complexes with othertained in Smad4-dominant negative cells.
Conclusion. These results indicate that Smad4 is essential DNA binding proteins, such as FAST1 [9] and coactiva-
for basal and TGF-–induced COL1A1 expression, and con- tors such as p300/CREB binding protein (CBP) [10].
tributes to the early, but not sustained TGF-–induced PAI-1
Smad6 and Smad7, which are structurally more distantlyexpression in mesangial cells. However, TGF-–induced FN
related to the other Smads, act as inhibitory Smads byexpression is independent of Smad4. In conclusion, Smad4
has a discriminate effect in mediating specific ECM molecules antagonizing the ligand-specific activity [11, 12].
stimulated by TGF- in mesangial cells. R-Smads and Smad4 are homologous in their amino
and carboxyl terminals, called the Mad homology do-
main (MH) 1 and 2, respectively. These domains areIt is now well established that the multifunctional cyto-
connected by a proline-rich linker region with variablekine, transforming growth factor-beta (TGF-) plays a
length and amino acid sequence. Direct DNA bindingcritical role in the development of a variety of progressive
is mediated through the MH1 domain, whereas the MH2
domain up-regulates transcriptional activity [6–8]. A C-ter-Key words: TGF-, signaling, diabetic nephropathy, kidney fibrosis,
type I collagen, fibronectin, PAI-1. minal part of the Smad4 linker region, which is called
Smad activation domain (SAD) (amino acids 274 to 321),
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binding with other proteins with transcriptional activity,
p300/CBP [10].
The role of the Smad pathway is critical for mediating
TGF-–induced genes such as cyclin-dependent kinase
inhibitors p15INK4B and p21CIP1/WAF1, c-fos, and Smad7 [13];
however, the role of Smads in matrix stimulation is con-
troversial [13–16]. For example, Smad4-deficient adeno-
carcinoma cells did not demonstrate stimulation of FN
or PAI-1 in response to TGF- [17], whereas in other
studies with the same cell type [15] or in Smad4-deficient
fibroblasts [16] TGF-–induced FN stimulation was not
impaired. The basis for these prior discrepant results
has not been clarified. With respect to collagens, TGF-
–induced collagen proteins were not altered in Smad4-
deficient fibroblasts [16]; however, individual types of
collagens were not evaluated. Smad3 has been found to
be involved in TGF-–induced stimulation of the  2
chain of type I collagen (COL1A2) in mesangial cells
[18, 19]; however, dependence of Smad3 on other matrix
molecules has not been evaluated. To date, no studies
have examined the role of Smad4 in mediating matrix
stimulation in mesangial cells.
The use of dominant-negative forms of transcription
factors has proven to be a helpful way to study gene
regulation in cultured cells [20]. To investigate the func-
tion of the Smad-pathway in ECM production, we gener-
ated several stably transfected mesangial cell lines that
Fig. 1. Stable expression of Smad4M4 and Smad4N4 mutant proteinshave a deletion in the linker region (Smad4M4) or have
in murine mesangial cells (MMC). A schematic representation of Smad4a deletion in MH1 of Smad4 (Smad4N4). In this study, deletion constructs based on the known sequence homology domains
we examined  1 type 1 collagen (COL1A1), PAI-1, and of the Smad family of proteins (A ). MH1 and MH2 domains that
are conserved between Smads are shown, respectively. This schema isFN production in wild-type mesangial cells and stably
adapted from [17]. MMC were transfected with Smad4M4 andtransfected Smad4 dominant-negative cell lines. Smad4N4 followed by selection in 800 g/mL of geneticin. To demon-
strate the expression of Flag-tagged Smad4 dominant-negative con-
structs, 20 g of total cellular protein was resolved on 10% sodium
METHODS dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels,
transferred to nitrocellulose membrane, and subjected to Western anal-Cell culture ysis using antibody for Smad4 (B) and the Flag epitope (C ). The position
of Flag-tagged Smad4 dominant-negative proteins are indicated by theA murine mesangial cell line (MMC) was used. Cells
arrow. WT is wild-type.were originally isolated from kidneys of SJL/J (H-2) nor-
mal mice and transformed with noncapsid forming SV-40
virus to establish a permanent cell line [21]. The cells
exhibit many phenotypic features of differentiated mes- were treated with recombinant human TGF-1 (R&D
Systems, Minneapolis, MN, USA) at 5 or 10 ng/mL. Cellsangial cells, including positive staining for desmin, vi-
mentin, and collagen types I and IV. The use of a trans- were harvested after a period of 2, 4, 24, and 48 hours
as specifically indicated.formed cell line was required as the process of stable
transformation would require multiple passages and lead
Establishment of stable dominant-negative cell linesto loss of differentiated characteristics in nontrans-
formed cells. Cells were maintained at 37C in a humidi- The dominant-negative constructs, 3 Flag-tagged
Smad4M4 and Smad4N4, were cloned into pcDNA3.1fied incubator with 5% CO2/95% air and propagated in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, vector, as indicated in Figure 1 and described previously
[10, 17]. They were kindly provided by M. de CaesteckerBRL, Grand Island, NY, USA) containing 100 mg/dL
d-glucose, 10% fetal calf serum (FCS), 100 U/mL penicil- (Division of Nephrology, Vanderbilt University, Nash-
ville, TN, USA). As a control for the effects of transfec-lin, 100g/mL streptomycin, and 2 mmol/L supplemental
glutamine. Cells were passaged every 72 hours by light tion, the empty vector pcDNA 3.1 (Invitrogen, Carlsbad,
CA, USA) was also utilized to generate stably transfectedtrypsinization. Experiments were initiated by resting cells
for 24 hours in 0.5% FCS. In some experiments, cells cells. For transfection of Smad4M4 and Smad4N4, sub-
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confluent MMC were transfected with 10 g of DNA per cence as described above and equal loading of proteins
was confirmed based on immunoblotting with an anti-100 mm dish using the polyamine transfection reagent
SuperFect (QIAGEN, Inc., Chatsworth, CA, USA), ac- body against -actin (Sigma Chemical Co., St. Louis,
MO, USA).cording to the manufacturer’s protocol. Stable transfec-
tants were selected and maintained in media containing
Northern analysis800 g/mL geneticin (Mediatech, Inc., Herndon, VA,
USA). Individual clones were isolated from pools of To assess whether TGF-1–induced COL1A1, PAI-1,
and FN mRNA expression were affected by Smad4geneticin-resistant cells by ring cloning.
dominant-negative proteins, MMC were treated with
Transcriptional response assays TGF-1 (5 ng/mL) for indicated time points and washed
with ice-cold phosphate-buffered saline (PBS). InitialThe p3TP-Lux luciferase reporter is a widely used
bioassay to determine responsiveness to TGF- [22]. The studies were performed with 5 and 10 ng/mL of TGF-1.
As the results were equivalent with respect to matrixp3TP-Lux construct has a 31 nucleotide, activator pro-
tein-1 (AP-1) site-containing a region of the collagenase stimulation at both doses, 5 ng/mL was chosen for the
repeated analyses. Total RNA was isolated using TRIpromoter, concatemerized 5 to an –400 nucleotide re-
gion of the PAI-1 promoter followed by 70 bp of the reagent (MRC, Inc., Cincinnati, OH, USA). Total RNA
(15 mg) was electrophoresed through a 1.2% agaroseadenovirus E4 promoter. Cells were seeded to 50% con-
fluence in six-well plates and incubated in medium con- gel with 0.67 mol/L formaldehyde and transferred onto
nylon membrane (NEN Research Products, Boston,taining 0.5% FCS for 24 hours. MMC were transiently
transfected using SuperFect (QIAGEN, Inc.) with 1 g/ MA, USA) by the capillary method and ultraviolet cross-
linked. The probe for mouse COL1A1 [24], PAI-1 [24],well of the p3TP-Lux reporter along with pcDNA3.1-
LacZ vector (generously provided by S. Sasaki, Kimmel and FN [25] has been described previously. Hybridiza-
tion and washing conditions were performed as describedCancer Center, Thomas Jefferson University, Philadel-
phia, PA, USA) as an internal control for transfection previously [26]. To standardize for loading, membranes
were stripped and reprobed with an 18S cDNA probe.efficiency. After 3 hours, cells were washed and allowed
to recover for 24 hours in growth medium. Cells were Densitometric analysis was performed as described pre-
viously [23] and mRNA levels were calculated relativeserum starved overnight prior to the addition of TGF-1
(10 ng/mL) for a further 24 hours. Luciferase activity to 18S. Additionally, in experiments with pooled clones
of stably transfected cells, mRNA levels were quanti-was determined in the cell lysate using the Luciferase
Assay System (Promega, Madison, WI, USA), and a tated via phosphoimager and the data expressed in rela-
tion to 18S.Dynatech Laboratories ML3000 luminometer (Dyna-
tech Laboratories, Chantilly, VA, USA). Activities were
Statistical analysisnormalized on the basis of -galactosidase expression
from pcDNA3.1-LacZ vector in all luciferase reporter Data are presented as mean  SEM. Means were
compared using either a two-sided paired t test for com-experiments. All experiments were repeated at least
three times with similar results. All assays were per- parisons within the group or a two-sided independent t test
between the groups. Bonferroni’s correction for multipleformed in triplicate, and represented as mean  SEM
of three independent transfections. comparisons was applied. When necessary (i.e., standard
deviations between the independent measurements were
Western blot analysis different) the nonparametric, Mann-Whitney U test was
used. A value of P  0.05 was considered significant.For detection of Flag-tagged Smad4 deletion mutant
proteins, cells were prepared as described previously [23] Instat Statistical Software for the PC 1990 GraphPAD
Software, Version 1.14 was used for the analysis.and total cellular protein was quantitated using the Bio-
Rad DC protein assay (Bio-Rad Laboratories, Hercules,
CA, USA). Total cellular protein (20 g) was resolved
RESULTS
on 10% sodium dodecyl sulfate-polyacramide gel elec-
Expression of Flag and Smad4 proteins in geneticin-trophoresis (SDS–PAGE) gels, transferred to nitrocellu-
resistant cell lineslose membrane (BioRad Laboratories), and subjected
to Western analysis using either a polyclonal antibody To generate cell lines, which stably expressed deletion
mutant forms of Smad4, two different kinds of deletionto the Flag epitope (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA) and monoclonal antibodies to mutants of Smad4 were used. The schematic constructs
of each mutant are shown in Figure 1A. As the Smad4Smad4 (Transduction Laboratory, Lexington, KY, USA).
Immunocomplexes were detected by enhanced chemilu- mutants are not affected in their R-Smad binding site, it
is not expected that the dominant-negative mutants wouldminescence (Pierce, Rockford, IL, USA). Immunoreac-
tive bands were detected by enhanced chemilumines- interfere with Smad2/3 phosphorylation or translocation
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into the nucleus. After transfection with Smad4M4 and
Smad4N4, stable transfectants were selected and main-
tained in media containing geneticin (800 g/mL). To
confirm overexpression of mutant Smad4, we examined
the expression of the exogenous Flag-tagged Smad4 pro-
tein using an antibody against the Flag epitope (Fig. 1).
As shown in Figure 1B, expression of the exogenous
Flag-tagged Smad4 could only be detected in transfected
MMC. Additionally, it is apparent that mutant Smad4 is
in excess of endogenous Smad4 in the stably transfected
mutant cell lines (Fig. 1C). We chose the cell line that
had the highest expression of Flag-tagged Smad4 protein
from 10 to 15 stably transfected clones.
Stable expression of Smad4M4 and Smad4N4 reduce
TGF-–induced transcriptional responses
To determine whether these cell lines, which expressed
Flag-tagged Smad4 mutant protein, have dominant-neg-
ative effects on TGF-–mediated gene induction, we
performed the transcriptional activity assay using p3TP-
Lux reporter construct. As shown in Figure 2, stimulation
with TGF- was capable of inducing activation of p3TP-
Lux in wild-type MMC. Wild-type MMC had a 10.8-fold
(10.78  1.97) increase of p3TP-Lux activity by TGF-1
Fig. 2. Expression of Smad4M4 and Smad4N4 proteins abolished(10 ng/mL) stimulation compared to basal level (arbi-
transforming growth factor- (TGF-) stimulated transcriptional re-trarily set as 1, P  0.05). In contrast, the Smad4M4
sponse. Wild-type murine mesangial cells (MMC) and MMC stably
cells had only a 2.0-fold increase (1.96  0.34, 18% of transfected with Smad4M4 and Smad4N4 constructs were cotrans-
fected transiently with 1 g of p3TP-Lux and 0.5 g of pcDNA3.1-wild-type) and Smad4N4 cells had only a 1.3-fold in-
LacZ as described in the Methods section. After 24 hours of starvation,crease (1.32 0.08, 15% of wild-type) with TGF- stimu-
cells were incubated in the absence () or presence of TGF-1 (10 ng/mL)
lation. Similar results were also obtained with 5 ng/mL () for an additional 24 hours. Cells were lysed and luciferase activity
was determined using the Promega’s Luciferase Assay System accordingof TGF-1 (data not shown). These results indicate that
to the manufacturer’s instructions. Luciferase activity is expressed asboth Smad4 deletion mutants clearly had dominant-neg-
the ratio of specific luciferase activity divided by the -galactosidase
ative effects on TGF-–induced transcriptional activity activity of the cotransfected vector. Data are shown as the mean 
SEM of triplicates from three separate experiments. Wild-type MMCof p3TP-Lux.
without TGF- at time 0 is arbitrarily set as 1. *P  0.05 vs. wild-type
without TGF-1; **P  0.05 vs. wild-type with TGF-1.The basal and TGF-–stimulated expression of
COL1A1 is dependent on Smad4
To examine whether the expression of COL1A1 with
TGF- stimulation was altered in MMC transfected with at 24 hours or 48 hours. This result indicates that both
basal and TGF-–induced COL1A1 expression is depen-Smad4M4 and Smad4N4, we analyzed the expression
of steady-state COL1A1 mRNA using Northern blot. dent on Smad4.
As shown in Figure 3, in wild-type MMC, the expression
The early, but not sustained PAI-1 stimulation byof COL1A1 stimulated with TGF-1 was significantly
TGF- is partly dependent on Smad4increased by 1.7-fold at 24 hours and 2.1-fold at 48 hours
compared to basal levels, respectively (P  0.05). Over- Northern analysis of PAI-1 mRNA was evaluated in
wild-type MMC and Smad4 dominant-negative MMC.expression of both Smad4M4 and Smad4N4 DN pro-
teins led to reduction of basal COL1A1 expression at Expression of PAI-1 mRNA in wild-type MMC was max-
imally stimulated 2 hours after TGF-1 addition (15.96baseline (wild-type, 1.00; Smad4M4, 0.52  0.04; P 
0.01; Smad4N4, 0.37  0.15; P 0.05), at 24 hours (wild- 0.36, P  0.005 vs. without TGF-1 at 2 hours) (Fig.
4). This early peak was significantly attenuated in bothtype, 1.40  0.06; Smad4M4, 0.66  0.14; P  0.01;
Smad4N4, 0.68  0.20; P  0.05), and at 48 hours (wild- Smad4M4 and Smad4N4 dominant-negative cell lines
compared to wild-type (Smad4M4, 1.94  0.34, P type, 1.06  0.13; Smad4M4, 0.27  0.12; P  0.01;
Smad4N4, 0.30  0.08; P  0.01). TGF-–stimulated 0.001; Smad4N4, 9.28  1.28, P  0.05 vs. wild-type with
TGF-1 at 2 hours). At 4 hours, TGF-–induced PAI-1COL1A1 expression did not show any increase as com-
pared to basal levels in the Smad4 DN cell lines either mRNA was significantly inhibited only in Smad4M4
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Fig. 3. The expression of 1 type I collagen
(COL1A1) is dependent on Smad4. (A ) Rep-
resentative Northern blot analysis of COL1A1
expression in total RNA lysates from murine
mesangial cells (MMC) [wild-type (WT)],
Smad4M4 (M4), and Smad4N4 (N4) domi-
nant-negative cell lines exposed to 5 ng/mL
of transforming growth factor-1 (TGF-1)
for the indicated time periods. The mem-
branes were stripped and reprobed for 18S
RNA levels to normalize for RNA loading.
(B) Quantitative data show the relative ex-
pression levels of COL1A1 measured by den-
sitometry after normalization for 18S from
three independent experiments. Bar graphs
are shown as mean  SEM expressed relative
to the expression in untreated wild-type
MMC. Wild-type MMC without TGF- at
time 0 is arbitrarily set as 1. Symbols are: (),
	TGF-; and (),
TGF-. *P 0.05; **P
0.01 vs. wild-type at time 0; #P  0.05; ##P 
0.01 vs. wild-type without TGF-1 at 24 hours;
‡P  0.05; ‡‡P  0.01 vs. wild-type without
TGF-1 at 48 hours. N.S. is not significant.
dominant-negative cell line (2.40  0.08, P  0.005 vs. Expression of FN stimulated with TGF- is
without TGF-1). In contrast to the early peak, the sus- independent of Smad4
tained stimulation of PAI-1 expression with TGF-1, at To determine if TGF-–induced FN was dependent
24 hours and 48 hours, was maintained in MMC trans- on Smad4, Northern blot analysis was performed. As
fected with Smad4M4 and Smad4N4, to similar levels shown in Figure 7, TGF-1 treatment of each cell line
as compared with wild-type MMC. Basal level of PAI-1 resulted in a significant increase of FN at 48 hours. At 48
mRNA was essentially the same at all time points evalu-
hours, TGF-–induced FN mRNA in MMC transfected
ated.
with Smad4M4 (3.48-  0.07-fold increase, P  0.05)To verify that the effects of Smad4 dominant-negative
and Smad4N4 (2.51-  0.15-fold increase, P  0.05)were not unique to single clones, pools of three clones
was similar to that in wild-type MMC (1.90-  0.04-foldthat showed high expression of Smad4 dominant-nega-
increase as compared to without TGF-, P 0.05). Basaltive Flag were also assessed. To control for transfection,
expression level of FN mRNA tended to be lower inMMC cells were stably transfected with an empty vector.
Smad4 dominant-negative cells.As shown in Figure 5, the effects of TGF-1 to stimulate
COL1A1 and PAI-1 at 24 and 48 hours are robust in
stably transfected empty vector cells. The Smad4 domi- DISCUSSION
nant-negative mutant cells had marked reduction of basal
This study examined the role of the Smad pathway inand TGF-–stimulated COL1A1 expression, whereas
TGF- regulation on ECM molecules in mouse mesan-PAI-1 stimulation was not affected. At the early time
gial cells using dominant-negative inhibition of Co-point (Fig. 6), PAI-1 stimulation is attenuated in pooled
Smad, Smad4. Since mice homozygous for the Smad4Smad4 DN cells. As expected, there is no induction of
COL1A1 with TGF-1 at 2 hours and 4 hours (Fig. 6). mutation die at embryonic day (E) 7.5 [27], transfection
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Fig. 4. The early, but not sustained, plasminogen activator inhibitor-1 (PAI-1) stimulation by transforming growth factor- (TGF-) is partly
dependent on Smad4. (A ) Representative Northern blot analysis of PAI-1 mRNA expression in total RNA lysates from murine mesangial cells
(MMC) [wild-type (WT)], Smad4M4 (M4), and Smad4N4 (N4) dominant-negative cell lines exposed to 5 ng/mL of TGF-1 for the indicated
time periods. (B) Bar graph shows the relative expression level of PAI-1 mRNA measured by densitometry after normalization for 18S from three
independent experiments. Data are shown as mean  SEM expressed relative to the expression in untreated wild-type MMC. Wild-type MMC
without TGF- at time 0 is arbitrarily set as 1. Symbols are: (), 	TGF-; and (), 
TGF-. *P  0.05; **P  0.005 vs. without TGF-1; #P 
0.05; ##P  0.001 vs. wild-type with TGF-1 at 2 hours; ‡ P  0.005 vs. wild-type with TGF-1 at 4 hours.
of Smad4-DN constructs is a useful approach to study the blasts; however, discrete collagen types and their chains
were not individually assessed. As we find a completegene regulation of ECM molecules in individual tissue-
specific cultures, such as glomerular mesangial cells. In Smad4 dependence on both basal and TGF-–stimulated
COL1A1 expression, it is likely that specific  chains ofthe present study, we established mouse mesangial cell
lines stably transfected with the Smad4-deletion mutant collagen isoforms are differentially regulated by Smad4.
Subsequent studies to assess each individual chain fromconstructs, Smad4M4 and Smad4N4, and demonstrated
a dominant-negative effect on TGF-–inducible tran- each collagen isoform will be required to resolve this
issue. Apart from Smads, the extracellular signal-regu-scriptional activity in these cell lines. Despite the almost
complete inhibition of TGF-–induced p3TP-Lux activ- lated protein kinase (ERK) and p38 mitogen-activated
protein kinase (MAPK) pathways have been implicatedity, there was a discriminate role of Smad4 in COL1A1,
PAI-1, and FN expression at the basal and TGF-– in TGF- stimulation of COL1A1. TGF-–induced
COL1A1 was dependent on the p38 MAPK pathway instimulated levels.
With regard to COL1A1, we demonstrated that the rat mesangial cells using a p38 inhibitor [28] and TGF-
–induced COL1A1 expression and promoter activityCOL1A1 expression was completely dependent on Smad4
at the basal level and after stimulation with TGF- (Fig. were inhibited by both ERK inhibitor and dominant-
negative form of ERK in human mesangial cells [29].4). This is the first description on the role of Smad4
on murine COL1A1 gene expression. Our studies are The mechanism by which Smad4 regulates COL1A1
expression is unclear. There are several reports thatdiscrepant from results obtained with murine embryonic
fibroblasts derived from Smad4 knockout mice [16]. In TGF- stimulates the COL1A2 gene through the Smad-
dependent pathway by inducing binding of a Smad-con-this study, TGF-–induced collagen proteins were simi-
larly stimulated in wild type and Smad4-deficient fibro- taining complex to a Smad-binding element (SBE) [18].
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Fig. 5. Smad4 dominant-negative cells have suppression of 1 type I
Fig. 6. The effect of early stimulation by transforming growth factor-1collagen (COL1A1) (A) but no effect on delayed stimulation of plasmino-
(TGF-1) on1 type I collagen (COL1A1) (A ) and plasminogen activa-gen activator inhibitor-1 (PAI-1) (B) in mixed clones. Pooled clones
tor inhibitor-1 (PAI-1) (B ) expression in empty vector and mixed clonesof Smad4M4 (M4) and Smad4N4 (N4) stably transfected cells were
of Smad4 dominant-negative cells. TGF-1 has no effect on COL1A1assessed for basal and transforming growth factor-1 (TGF-1)–stimu-
at the early time points tested. As noted previously, basal levels oflated expression of COL1A1 and PAI-1. Murine mesangial cells (MMC)
COL1A1 are suppressed in pooled clones of Smad4M4 and SmadN4with stable transfection with an empty vector were used as control.
stably transfected cells at these time points. TGF-1 markedly stimu-Similar to data shown in Figures 3 and 4, there is marked inhibition of
lates PAI-1 at the early time points, whereas there is a reduction ofbasal and TGF-–stimulated levels of COL1A1 at 24 hours and 48
PAI-1 stimulation in the pooled clones of Smad4M4 and SmadN4hours in Smad4 dominant-negative cells. Basal levels of PAI-1 are not
stably transfected cells. The data show the relative expression levels ofaffected in Smad4 dominant-negative cells and there is no decrease in
COL1A1 and PAI-1 measured by phosphoimager after normalizationTGF-1 stimulation of PAI-1 at 24 hours and 48 hours. The data show
for 18S from three independent experiments. Bar graphs are shown asthe relative expression levels of COL1A1 measured by phosphoimager
mean  SEM expressed relative to the expression in untreated murineafter normalization for 18S from three independent experiments. Bar
mesangial cells (MMC). Empty vector transfected MMC without TGF-graphs are shown as mean  SEM expressed relative to the expression
(Control) is arbitrarily set as 1. *P  0.05 vs. control.in untreated MMC. Empty vector transfected MMC without TGF-
(Control) is arbitrarily set as 1. *P  0.05 vs. control.
An SBE (CAGACA sequence) in the COL1A2 pro- sion without directly binding to DNA regulatory ele-
ments. For example, the TGF-–responsive element ofmoter recognized by Smad3/4 has been identified [30],
but no comparable element has been identified within the p21 gene does not contain a CAGA box; however,
Smad proteins may transactivate the Sp1-dependent p21the 5 flanking region, the promoter or the first intron
of human COL1A1 [30, 31] or the murine promoter promoter possibly by functionally interacting with Sp1
[32]. A 220 bp region of the transcription start site ofof COL1A1 (unpublished observation, K.T.). However,
Smads may regulate TGF-–induced COL1A1 expres- human COL1A1 contains sequences sufficient for its
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Fig. 7. Transforming growth factor- (TGF-)–induced fibronectin expression of fibronectin is independent of Smad4. (A ) Representative Northern
blot analysis of fibronectin in murine mesangial cells (MMC) [wild-type (WT)], Smad4M4 (M4) and Smad4N4 (N4) dominant-negative cell
lines exposed to 5 ng/mL of TGF-1 for the indicated time periods. Total RNA (15 g) was electrophoresed, transferred onto nylon membrane,
and probed with a murine probe for fibronectin. The membranes were stripped and reprobed for 18S rRNA levels to normalize for RNA loading.
(B) Bar graph shows the relative expression level of fibronectin mRNA measured by densitometry after normalization for 18S. Data are shown
as mean  SEM from three independent experiments and expressed relative to the expression in untreated wild-type MMC. Wild-type MMC
without TGF- at time 0 is arbitrarily set as 1. Symbols are: (), 	TGF-; and (), 
TGF-. *P  0.05 vs. without TGF-1.
basal transcription and is also sufficient for its inducibility Smad3/Smad4 and Sp1, independent of Smad/DNA
binding. Both these mechanisms may be required forby TGF- [31]. Two partially conserved glucocorticoid
(GC)-rich sequences in this region of the COL1A1 pro- full induction of the PAI-1 promoter. In addition, the
results of the present study indicates that only the earlymoter are functional binding sites for Sp1 [33, 34]. More
recently, a homologous region in the rat COL1A1 pro- expression of TGF- is partly dependent on Smad4 and
the sustained expression is completely independent ofmoter, which is flanked by GC-rich Sp1 binding sites,
was found to be involved in TGF-1 stimulation via Smad4. The complex, time-dependent role of Smad4 in
TGF-–induced PAI-1 stimulation may help to explainbinding of CCAAT binding factor (CBF) [35]. The bind-
ing of CBF to this site is also important for basal the divergent results from prior studies.
TGF-–induced FN stimulation was not altered in theCOL1A1 promoter activity [35, 36]. These reports sug-
gest that Smads may form complexes with Sp1 and possi- Smad4 dominant-negative cell lines transfected with ei-
ther the Smad4M4 or the Smad4N4 construct (Fig. 7).bly CBF to play an important role in mediating basal and
TGF-–induced COL1A1 expression without binding to This result is consistent with prior observations that the
Smad pathway was dispensable for TGF-–induced FNthe COL1A1 promoter directly [18, 32, 33, 35].
In the case of PAI-1, there was Smad4 dependence synthesis. In Smad4-deficient cell lines, such as MDM-
MB 468, BxPC3, and SW480.7 cell line [15], Smad4-for the TGF-–induced PAI-1 expression at the early
period (2 to 4 hours), but no dependence at the sustained deficient fibroblasts [16] and Smad2- and Smad3-defi-
cient fibroblasts [13], TGF-–induced FN stimulationperiod (24 to 48 hours) (Fig. 5). Based on prior studies, it
appears that Smad2 and Smad3 are critical and necessary was maintained. It is unclear which TGF- signaling
pathway is critical for FN production in mesangial cells.factors for TGF-–induced PAI-1 expression at the early
time points (5 hours) [13]. However, the role of Smad4 in Hocevar, Brown, and Howe [15] demonstrated that
TGF-–induced FN expression was dependent on Smad-PAI-1 expression with TGF- stimulation has revealed
conflicting results [14–16]. Sirard et al [16] identified independent c-Jun NH2 terminal kinase/stress-activated
protein kinase (JNK/SAPK) pathway. TGF- has beenSmad4-dependent (	730) and -independent (	580) ele-
ments in the PAI-1 promoter sequence. Datta, Blake, shown to activate JNK/SAPK in a number of cell types
[38]; however, not in mesangial cells [28]. We have pre-and Moses [37] suggest that the PAI-1 promoter is in-
duced by TGF- primarily by two mechanisms. First, the viously reported that TGF- stimulates the protein ki-
nase A signaling pathway and that protein kinase APAI-1 promoter is strongly activated by TGF-–induced
binding of a Smad3/Smad4 containing nuclear complex activation contributed to TGF- stimulation of cyclic
adenosine monophosphate (cAMP) response elementto the CAGA box. Second, the proximal promoter (	82
and –40), containing two Sp1 sites, mediates moderate binding protein (CREB) phosphorylation and FN gene
expression [39]. The p38 MAPK pathway also has beeninduction through TGF-–induced interaction between
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